Objective: The purpose of the present study was to demonstrate clinical equivalence between the application of collagenase ointment at 24- and 48-hour intervals in the healing of pressure ulcers.
Collagenase clostridium histolyticum is under clinical development by Endo International and currently in Phase III for Unspecified Musculoskeletal Disorders.
Results that may be inaccessible to you are currently showing.